AN OPEN-LABEL, MULTICENTER, PILOT STUDY TO EVALUATE THE PERFORMANCE AND SAFETY OF NEURAGEN® 3D NERVE GUIDE MATRIX

Administered By

Awarded By

Contributors

Start/End

  • January 18, 2022 - January 31, 2025